JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹2.07 Cr | ₹2.16 Cr | ₹3.24 Cr | ₹1.86 Cr | ₹3.09 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹2.07 Cr |
Mar2023 | ₹2.16 Cr |
Mar2022 | ₹3.24 Cr |
Mar2021 | ₹1.86 Cr |
Mar2020 | ₹3.09 Cr |
How is Deferred Tax Assets / Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2.07 Cr | -4.16 | |
Mar2023 | ₹2.16 Cr | -33.20 | |
Mar2022 | ₹3.24 Cr | 74.18 | |
Mar2021 | ₹1.86 Cr | -39.88 | |
Mar2020 | ₹3.09 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,637.2 Cr | 6.9% | 6.6% | 89% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 6.9% |
6.6% |
89% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses